Quick Answer
Accustem Sciences Inc. reported Stockholders Equity of -$3.31 million for the year ending 2024.
- Accustem Sciences Inc. showed a decrease of -56.9% in Stockholders Equity from 2023 to 2024.
- This data is from Accustem Sciences Inc.'s annual report (Form 10-K), filed with the SEC on April 3, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $1.31 million | Q2 2021: $1.26 million | Q3 2021: $1.19 million | Q1 2022: $2.69 million | Q2 2022: $1.65 million | Q3 2022: $797.7 thousand | Q1 2023: -$946.7 thousand | Q2 2023: -$1.31 million | Q3 2023: -$1.89 million | Q4 2023: -$2.11 million | Q1 2024: -$2.62 million | Q2 2024: -$2.88 million | Q3 2024: -$3.19 million | Q4 2024: -$3.31 million | Q1 2025: -$2.16 million | Q2 2025: -$2.53 million | Q3 2025: -$2.91 million.
- Over the full 5 years of available data (2020 to 2024), Accustem Sciences Inc.'s Stockholders Equity has declined by 353.0%.
- Historical annual values: Fiscal year 2024: -$3.31 million | Fiscal year 2023: -$2.11 million | Fiscal year 2022: -$139.6 thousand | Fiscal year 2021: $650.7 thousand | Fiscal year 2020: $1.31 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: